This seminar will be presented as an online/virtual event

Helping GT entrepreneurs learn how to fund and commercialize their technology

"Navigating the Risks and Opportunities in Regenerative Medicine Product Development - Examples in Orthopaedic Surgery"

Scott Bruder, M.D., Ph.D.
Founder and Chief Executive Officer
Bruder Consulting & Venture Group

AGENDA
11:00 a.m.       Seminar
12-2:00 p.m.    Individual or small-group discussions with Dr. Bruder **

**All spots to meet with Dr. Bruder individually or in small groups have now been filled.

RSVP for Seminar

BlueJeans Seminar Participation Link

Scott Bruder, M.D., Ph.D., has enjoyed a long and distinguished career in the discovery, development and commercialization of products to diagnose and treat patients around the world.  He founded the Bruder Consulting and Venture Group in 2015 after 25 years in the industrial sector, serving in the C-Suites of Stryker Corporation as the Chief Medical and Scientific Officer, and at BD, as the Chief Science and Technology Officer, where he also led Corporate Business Development.  Previously, while at Johnson & Johnson, he and his team built a portfolio of tissue repair products for the DePuy franchise before establishing a new business unit known as J&J Regenerative Therapeutics, LLC.  Earlier in his career, he was the first scientist hired by Osiris Therapeutics, a mesenchymal stem cell company based on the work of his PhD mentor, Prof. Arnold Caplan.  In addition to his tenure through industry, Dr. Bruder has maintained an active academic presence, serving as an Adjunct Professor of Biomedical Engineering at Case Western Reserve University since 2011, after 13 years as adjunct faculty in the Department of Orthopaedic Surgery.  Currently, he also serves on the Board of Directors of both publicly held and private equity backed medical device companies.

​Dr. Bruder's inventions, technologies and teams have launched dozens of products, earning billions of dollars for his employers and patent licensors.  He has published more than 125 original articles, book chapters and abstracts, and lectured extensively around the world. He is the recipient of numerous honors, and is both the youngest and only industry scientist to receive the Kappa Delta Award from the American Academy of Orthopaedic Surgeons, the Marshall R. Urist Award for Excellence in Tissue Regeneration Research from the Orthopedic Research Society, and the Pierre Galletti Award from the American Institute for Medical and Biological Engineering, all of which represent the highest scientific honors bestowed by these organizations. He also served three years as the Industry Member on the FDA Advisory Committee on Cellular, Tissue and Gene Therapies.  Dr. Bruder received his Sc.B. from Brown University, and both his M.D. and Ph.D. from CWRU School of Medicine before post-graduate clinical training at the Albert Einstein Medical Center and the University of Pennsylvania. Scott resides in Northern New Jersey with his beloved wife and dog, and has two daughters in college and graduate school. 

Support for this series provided by the Parker H. Petit Institute for Bioengineering and Bioscience and VentureLab.